Cognitive Behavioral Resistance Exercise for Head and Neck Cancer
Trial Summary
What is the purpose of this trial?
This clinical trial examines a group-mediated cognitive behavioral resistance exercise intervention in head and neck cancer patients who are undergoing chemoradiation treatment. Chemoradiation is the established standard of care for locally advanced head and neck cancer patients. However, many head and neck cancer patients experience clinically meaningful declines in muscle mass, physical function, and quality of life during and following treatment. Resistance exercise has been shown to improve muscle mass, body composition, and physical function when integrated with appropriate standard of care nutritional counseling/supplementation. This trial may help researchers determine the important of integrating exercise interventions with routine cancer care.
Research Team
Dukagjin Blakaj, MD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Eligibility Criteria
This trial is for adults over 18 with head and neck cancer, specifically HPV+ stage III-IV squamous cell carcinomas, who are undergoing chemoradiation. They must be cleared by their doctor to do resistance exercises and have no severe heart conditions or other medical issues that make exercise unsafe. Pregnant or nursing women and those with prior cancers not eligible.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Resistance Training (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor
Dr. David Cohn
Ohio State University Comprehensive Cancer Center
Interim Chief Executive Officer since 2022
MD, MBA
Dr. David Cohn
Ohio State University Comprehensive Cancer Center
Chief Medical Officer since 2018
MD